Skip to Content

H 13 9 (Abacavir Sulfate 300 mg (base))

Pill with imprint H 13 9 is Yellow, Capsule-shape and has been identified as Abacavir Sulfate 300 mg (base). It is supplied by Camber Pharmaceuticals, Inc..

Abacavir is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Abacavir 300 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for H 13 9

Abacavir Sulfate

Imprint:
H 13 9
Strength:
300 mg (base)
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Camber Pharmaceuticals, Inc.
National Drug Code (NDC):
31722-0557

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide